first, Chinese is the world's first children's country, by 2025, the population of children aged 0-14 years in China in more than 210000000 people, the scale China children drug market up to 19500000000 yuan.
therefore, recall Johnson series, has nothing to do with the Chinese children pharmaceutical companies, this is China pharmaceutical enterprises sad.
Johnson is active recall, not because the user created an adverse reaction to market products, the negative impact is not as we imagined, this self attitude and recall the timeliness, China probably no enterprise can compared with. Our country enterprise in many ways of learning and the catch-up phase, also do not talk to the repair and replacement.
but again, because nothing, only fully illustrated China children's medicine market contains huge growth opportunities, because the market is lack of concentration, lack of the boss, China children's medicine market is a huge reserves of gold!
general manager Lou Xiangpeng
Johnson recall, China children's medicine to these children?
third, Johnson is recalled, China's enterprises to recall the attitude and quality control level with far apart.
China children's medicine huge market opportunity for
second, in the domestic market, children's medicine market, including Johnson, although the fierce competition, but the brand concentration is not high, Tylenol accounted for only a little more market share in the similar products in the market,<a href="http://www.najaboxers.com/images/celine-nihon-outlet-153.html">セリーヌ バッグ</a> http://www.najaboxers.com/images/celine-nihon-outlet-153.html, substitute phenomenon is not obvious. Just as the "contac" by PPA under the frame, but no brand can also make the boss, because the brand leader based backup distance too far.
first, China enterprises did not enter the international pharmaceutical market. Chinese pharmaceutical original ability is weak, the vast majority of products are generic,<a href="http://www.larotec.com/new/pdf/bottega-veneta-outlet-287.html">ボッテガヴェネタ 店舗</a> http://www.larotec.com/new/pdf/bottega-veneta-outlet-287.html, non patent drug, do not enter the world in the drug market, no status, fill these impossible.
the answer is no..
third, traditional Chinese medicine has a lot of potential field. Now many mothers consumers, meet the children diarrhea.
second, 90% more drug without children cold, have a fever, a special formulation, dyspepsia, diarrhea, sweating, convulsion of children common disease, mainly by self consumption. But many category, brand leadership is not prominent or even virtual. Therefore, children's drug market both in the extension and connotation, to tap the potential and value are large.
recently, a wide range of subsidiary McNeil ConsumerHealthcare global pharmaceutical giant Johnson's recall of children's non prescription drugs (Merrill Lynch, Tylenol), which is fifth McNeil in no time due to product quality problems occurred to recall a year. Johnson recall, Chinese children pharmaceutical companies can fill up?
|
